Case Study: Microba advances gut microbiome profiling with Illumina NovaSeq 6000

Microba sequences 92 samples in 2 days with Illumina NovaSeq 6000

The customer, Microba, a microbial genomics company co-founded by Dr. Philip Hugenholtz, aimed to provide high-resolution gut microbiome profiling to consumers. Their challenge was to find a reliable, high-throughput, and scalable next-generation sequencing (NGS) platform to perform shotgun metagenomic sequencing for their commercial service.

Illumina provided the solution with its NovaSeq 6000 System. This technology enabled Microba to sequence samples rapidly and generate five gigabytes of data per sample, which was then processed through an automated bioinformatic pipeline. The results were a detailed, consumer-friendly report on an individual's gut microbiome. The implementation of Illumina's technology allowed Microba to achieve a fast sample-to-data turnaround time and reliably scale its services for future growth into international markets.

Microba